Navigation Links
Discover Advances in Parathyroid Hormone Testing in DiaSorin Webinar

Parathyroid hormone (PTH) is an 84 amino acid that plays a key role in phosphocalcic metabolism. Its measurement is essential to diagnose and treat primary hyperparathyroidism and to evaluate chronic kidney disease-mineral and bone disorders (CKD-MBD). PTH determination is not an easy task, mainly because of the many similar fragments that circulate in our blood.

Because these fragments are recognized differently by the various assays, the values obtained are often very different between “intact” kits. Up to now, 3rd generation PTH assays have not demonstrated any clinical benefit over intact PTH assays. However, PTH standardization can be achieved only with 3rd generation and it will be impossible to standardize assays using the intact PTH kits, because of variable cross-reactivities to fragments.

It is important to carefully select the “normal” subjects to establish reference ranges that allow the proper interpretation of the patient’s PTH results. These “normals” should not have secondary hyperparathyroidism and should have eGFR, 25(OH)D, calcium and phosphorus levels within a normal range. Unfortunately, manufacturers have not judiciously selected their “normals”, leading to falsely elevated PTH reference ranges. Using correctly established PTH reference ranges will assist physicians in correctly classifying HD patients in the appropriate bone turnover category.

Participants of the webinar will better understand the importance of good reference range establishment for PTH and PTH standardization. They can also expect to learn how best to get up-to-date information regarding PTH stability.

Dr. Etienne Cavalier, professor of clinical chemistry at the University of Liege and Head of the Department of Clinical Chemistry at the CHU de Liege, will be the presenter for this webinar.

Cavalier earned both a Master of Sciences in pharmaceutical sciences and an Advanced Master in clinical biology from the University of Liege. He then went on to earn his PhD in Pharmaceutical and Biomedical Sciences from the same university. In his current role, Cavalier is the professor of clinical chemistry at the University of Liege and head of the Department of Clinical Chemistry at the CHU de Liege. His main research topics are linked with the phosphocalcic metabolism, renal function, frailty and sarcopenia.

LabRoots will host the free webinar on February 15, 2017, beginning at 9:00 a.m. PT, 12 p.m. ET. To find out more on this event, learn about continuing education credits or to register for free, click here.

About DiaSorin
Headquartered in Italy and listed in the FTSE Italia Mid Cap Index, DiaSorin is a global leader in the In Vitro Diagnostics (IVD) field. For over 40 years the Company has been developing, producing and marketing reagent kits for IVD worldwide. Through constant investments in research and development, and using its own distinctive expertise in the field of immunodiagnostics to deliver a high level of innovation, DiaSorin offers today the broadest range of specialty tests available in the immunodiagnostics market and new tests in the molecular diagnostics markets, which identify DiaSorin Group as the IVD “diagnostics specialist.”

About LabRoots
LabRoots is the leading scientific social networking website and producer of educational virtual events and webinars. Contributing to the advancement of science through content sharing capabilities, LabRoots is a powerful advocate in amplifying global networks and communities. Founded in 2008, LabRoots emphasizes digital innovation in scientific collaboration and learning, and is a primary source for current scientific news, webinars, virtual conferences, and more. LabRoots has grown into the world’s largest series of virtual events within the Life Sciences and Clinical Diagnostics community.

Read the full story at

Source: PRWeb
Copyright©2016 Vocus, Inc.
All rights reserved

Related medicine news :

1. Center For Discovery's Resilience Chino Hills Residential Mental Health Program for Adolescent Girls Now Open and Accepting Clients Announcement
2. Doctor Discovers Cure for Canadian Healthcare System
3. The Interplay of Kinase Broad Profiling and Phenotypic Screening Discussed in DiscoverX Webinar
4. The TouchPoint Solution Arizona Neuroscientist Discovers New Technology to Alleviate Stress and Anxiety
5. Mike Schubert Joins eDiscovery Leader Discovia as Vice President of Client Solutions
6. Use of Endotine Discovered to Increase Front Hair Density in Hairline Lowering/Forehead Reduction Surgery
7. Author Seeks to Help Others Discover Their Limitless Creative Power
8. National Eye Institute “Facts about Dry Eye” Web Page Omits Recent Discoveries Reports Water Advocate Sharon Kleyne
9. Innovations to Showcase AsedaSciences® for its Breakthroughs in Flow Cytometry, Airing via Discovery
10. Top Speakers Announced for II International Conference on Clinical Sciences and Drug Discovery
11. Stem Cell Discovery Might Lead to Fix for Gene Mutation Behind Hereditary Hearing Loss
Post Your Comments:
(Date:9/3/2020)... , ... September 03, 2020 , ... ... memory impairment, has announced the Best Memory Care Facilities in Louisville, KY. The ... features and amenities. , According to the Alzheimer’s Association , 5.6 ...
(Date:9/1/2020)... ... September 01, 2020 , ... Feeding Matters , the first ... Pediatric Feeding Disorder (PFD), is pleased to announce that the U.S. Centers for Disease ... (R code) in the next edition of the U.S. International Classification of Diseases ...
(Date:8/31/2020)... ... ... your dear friend has cancer? , It’s hard to hear your doctor say the words ... the shock wears off, the questions and fears can be overwhelming. , How should I ... Words are failing me. I’m scared. I want to DO something. , We’ve talked to ...
(Date:8/31/2020)... ... August 31, 2020 , ... Smile Brands ... groups in the United States, today announced the grand opening of another affiliated ... , Patients will enjoy convenient hours, a comfortable office, and full-service care at ...
(Date:8/31/2020)... Conn. (PRWEB) , ... August 31, 2020 , ... ... device intended to improve outcomes for patients with advanced heart failure, today announced ... (SBIR) grant in the amount of $555,358 from the National Heart, Lung, and ...
Breaking Medicine News(10 mins):
(Date:8/31/2020)... SEATTLE (PRWEB) , ... August 31, 2020 , ... ... technology research and advisory guide, has named Cloudticity a Gold winner in the ... are industry and peer recogniti o ns from Network Products Guide ...
(Date:8/28/2020)... ... ... Dr. Mark Surrey has been in practice for over 25 years. ... in the Department of OBGYN at UCLA’s David Geffen School of Medicine. , ... and is a Clinical Director of Fellowship Training for UCLA & Cedars Sinai Reproductive ...
(Date:8/27/2020)... ... 2020 , ... InfoMC, a leading provider of cloud-based healthcare ... System and Organizational Controls (SOC) 1® Type 2 and SOC 2® Type 2 ... achievements reflect their long-standing commitment to privacy, security, and risk management, while giving ...
Breaking Medicine Technology: